Savings With Biosimilar Filgrastim Unclear Savings With Biosimilar Filgrastim Unclear

Projected cost savings from switching to biosimilar filgrastim from the reference drug depend on the data analyzed.Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news